![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Welcome! Items in Cart Quick Order
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AIF Antibodies
AIF specific siRNA, sHRNA Plasmid and shRNA Lentiviral Particles gene silencers are also available.These include:
BACKGROUND
A key event in the apoptotic process is the opening of the mitochondrial permeability transition pore, an event that is regulated by Bcl-2 family proteins, resulting in the release of several proteins from the mitochondrial intermembrane space. Several of these proteins participate in apoptosis, including cytochrome c, procaspases-2, -3 and -9, and AIF (apoptosis-inducing factor). AIF was shown to cause DNA fragmentation and chromatin condensation, and to induce the release of cytochrome c and caspase-9 from mitochondria. Bcl-2 overexpression was shown to prevent the release of AIF from mitochondria, but not to block its apoptogenic activity. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
